10 New Drugs for Primary Care: Q1 2019

Highlights: The first liquid solution of colchicine for prophylaxis of gout, the first generic version of Advair Diskus, and 8 more new and approved drugs.

US Food and Drug Administration (FDA) new drug approvals in the first quarter of 2019 include numerous “firsts” for treatment of various conditions often seen in primary care. Below you will find details on the first liquid solution of colchicine for prophylaxis of gout; the first generic version of the Advair Diskus® for asthma and COPD maintenance; the first new mechanism of action to treat major depressive disorder in nearly 30 years; plus 7 more.

Related Videos
Primary Care is the Answer to the Migraine Care Gap, Says Headache Specialist
Migraine Management Pearls for Primary Care with Neurologist Jessica Ailani, MD
Tezepelumab Significantly Reduced Exacerbations in Patients with Severe Asthma, Respiratory Comorbidities
Related Content
© 2023 MJH Life Sciences

All rights reserved.